| Stage | IMKTA | % of rev | FSTR | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.4B | 100.00% | $139M | 100.00% | IMKTA ×9.88 |
| Gross profit | $332M | 24.30% | $31M | 22.28% | IMKTA +2.0pp |
| Operating income | $34M | 2.52% | $6M | 4.44% | FSTR +1.9pp |
| Pre-tax income | $33M | 2.41% | $5M | 3.93% | FSTR +1.5pp |
| Net income | $26M | 1.89% | $3M | 2.25% | FSTR +0.4pp |
| Stage | IMKTA | FSTR | Gap · A − B |
|---|---|---|---|
| Revenue | $1.4B100.00% | $139M100.00% | IMKTA ×9.88 |
| Gross profit | 24.30%$332M | 22.28%$31M | IMKTA +2.0pp |
| Operating income | 2.52%$34M | 4.44%$6M | FSTR +1.9pp |
| Pre-tax income | 2.41%$33M | 3.93%$5M | FSTR +1.5pp |
| Net income |
| 1.89%$26M |
| 2.25%$3M |
| FSTR +0.4pp |
No disclosed counterparties: IMKTA, FSTR.